Thyroid Neoplasms Clinical Trial
Official title:
Clinical Investigations on Cytokin-Gradients in Hypo/Euthyroid Patients. Evaluation of Expression of Different Pro-and Anti-Inflammatory Cyto-/Chemokines in Skin Wounds After Surgery of Benign Goitres (Struma Multinodosa) or Malignant Diseases of Thyroid Gland (Papillary Thyroid Carcinoma) in Correlation to the Status of Wound Healing of the Neck Wound
Main goal of this clinical investigation is to investigate different cytokines in wound fluids of euthyroid vs. hypothyroid patients. As a primary endpoint we want to evaluate if different cytokine levels in euthyroid vs. hypothyroid patients exist and to what extent these cytokines differ. Our targeted cytokines are: IL6, IL10, TNFa and MCP-1. From the literature these 4 factors seem to be the most reasonable to measure and to focus on. Additionally we focus on these 4 factors for financial reasons, technically there wouldn't be a problem to measure more, which is correlated with higher costs. Besides, more than 6 factors would mean larger amounts of sample fluids needed, which would cause technical problems. These factors don`t have to change in the same direction. Secondarily, we believe that differences in cytokine profiles of hypothyroidism vs. euthyroidism will correlate to differences in duration and clinical characteristics of the wound healing process.
n/a
Allocation: Randomized, Masking: Open Label, Primary Purpose: Basic Science
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00537095 -
Efficacy and Safety of Vandetanib (ZD6474) in Patients With Metastatic Papillary or Follicular Thyroid Cancer
|
Phase 2 | |
Recruiting |
NCT04139096 -
Genetic Susceptibility to Radiation Induced Thyroid Cancer
|
||
Completed |
NCT00754182 -
Subcuticular Suture Versus Synthetic Glue in Thyroidectomy Incision
|
N/A | |
Completed |
NCT00094055 -
Study of the Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Thyroid Cancer
|
Phase 2 | |
Completed |
NCT00148213 -
Clinical Evaluation of a New Highly Sensitive Thyroglobulin Assay in Differentiated Thyroid Carcinoma
|
N/A | |
Recruiting |
NCT06398795 -
Dual-port Trans-subclavian Thyroid Endoscopic Surgery
|
N/A | |
Recruiting |
NCT01005654 -
Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms
|
||
Active, not recruiting |
NCT05579782 -
Assessing Benefits of NIRAF Detection for Identifying Parathyroid Glands During Total Thyroidectomy
|
N/A | |
Completed |
NCT01437254 -
To Compare Safety and the General Imaging Pattern of Cyclotron Produced Technetium vs. Generator Produced Technetium in Patients With Thyroid Cancer
|
Phase 1 | |
Recruiting |
NCT03160274 -
Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
|
||
Completed |
NCT00984282 -
Nexavar® Versus Placebo in Locally Advanced/Metastatic RAI-Refractory Differentiated Thyroid Cancer
|
Phase 3 | |
Completed |
NCT01292044 -
The Role of Elastography in the Diagnosis of Thyroid Nodules
|
N/A | |
Terminated |
NCT04644315 -
A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors
|
Phase 2 | |
Active, not recruiting |
NCT02418247 -
Minimize Radioactive Iodine Ablation Of Remnant Thyroid in Differentiated Thyroid Cancer
|
Phase 2/Phase 3 | |
Completed |
NCT00467506 -
Phase II Two-step Radioimmunotherapy Clinical Study in Medullary Thyroid Carcinoma
|
Phase 2 | |
Completed |
NCT02430714 -
Post-marketing Surveillance of Lenvatinib Mesylate (Lenvima Capsule) in Patients With Unresectable Thyroid Cancer (Study LEN01T)
|
||
Recruiting |
NCT04396912 -
Post-thyroidectomy Vocal Cord Paralysis Along With Hypocalcemia: STROBE - Guided Prospective Cohort
|
||
Enrolling by invitation |
NCT04411290 -
Malignancy Predictors, Bethesda and TI-RADS Scores Correlated With Final Histopathology in Thyroid Diseases
|
||
Recruiting |
NCT04410601 -
Post-thyroidectomy Dysphagia: An International Multicentric CONSORT - Compatible RCT
|
N/A | |
Completed |
NCT03469310 -
Minimizing Narcotic Analgesics After Endocrine Surgery
|
Phase 4 |